L. Su

The long-term impact of tumor burden in pT3N0M0 esophageal squamous cell carcinoma

Tingting Li, Xiaobin Fu, L. Xiao, 2019, Medicine.

Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancer

L. Su, Xiaofeng Li, Shaowei Lin, 2022, Frontiers in Oncology.

Long-term impact of prognostic nutritional index in cervical esophageal squamous cell carcinoma patients undergoing definitive radiotherapy.

Tingting Li, Xiaobin Fu, L. Su, 2019, Annals of translational medicine.

Postoperative chemoradiotherapy is superior to postoperative chemotherapy alone in squamous cell lung cancer patients with limited N2 lymph node metastasis

L. Su, Yaqing Dai, Jiancheng Li, 2019, BMC Cancer.

Intravenous Patient-Controlled Analgesia Versus Oral Opioid to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase II Trial.

L. Su, Yushuang Luo, Xiaofeng Li, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

POF (paclitaxel/oxaliplatin/5-fluorouracil/leucovorin) vs. SOX/CAPOX/FOLFOX as a postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer: Study protocol for a randomized controlled trial, FNF-014 trial

Luchuan Chen, L. Su, R. Lin, 2022, Frontiers in Medicine.

A kinase‐interacting protein 1 may serve as a potential biomarker for deteriorative tumor features and poor prognosis in gastric cancer patients

Qinlian He, Y. Ye, L. Su, 2020, Journal of clinical laboratory analysis.